Skip to main content
. Author manuscript; available in PMC: 2014 Oct 9.
Published in final edited form as: Ann Hematol. 2013 May 10;92(10):1335–1343. doi: 10.1007/s00277-013-1776-3

Figure 2.

Figure 2

In patients with therapy-related myelodysplastic syndromes who did not receive hematopoietic stem cell transplant, the presence or absence of significant bone marrow fibrosis has no impact on cumulative incidence of transformation to acute myeloid leukemia (A) (p=0.926, log-rank test) or overall survival (P = 0.972, log-rank test) (B).